ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Oral Selective Estrogen Receptor Degrader After Endocrine Therapy With a Cyclin-Dependent Kinase 4/6 Inhibitor.

Ryo Nishihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.